DELFI Diagnostics, Inc. is seeking a contract PM shift CLS to perform high complexity cancer-detection tests using next-generation sequencing. You will collaborate with automation, assay development and tech transfer teams to build scalable clinical infrastructure.
Qualifications include a CA CLS/CGMBS license, 2+ years of CL lab experience, familiarity with CAP Molecular Pathology, and strong communication skills for cross-functional audiences. PM shift applies.
#J-18808-Ljbffr
As a Clinical Lab Scientist: NGS Cancer Diagnostics (PM Shift), you will play an important part at Delfi Diagnostics, Inc. in Palo Alto, CA, United States.
The position is based in Palo Alto, CA, United States.
This opportunity is part of our work in Bio & Pharmacology & Health.
The advertised compensation is 88.000 - 103.000.
We aim to respond to suitable candidates as soon as possible.